MedPath
FDA Approval

Phenytoin Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 18, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phenytoin(50 mg in 1 mL)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenytoin Sodium

Product Details

NDC Product Code
0641-2555
Application Number
ANDA084307
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
January 18, 2024
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 0.4 mL in 1 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACTQuantity: 0.1 mL in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
PhenytoinActive
Code: 4182431BJHClass: ACTIBQuantity: 50 mg in 1 mL

Phenytoin Sodium

Product Details

NDC Product Code
0641-0493
Application Number
ANDA084307
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
January 18, 2024
WATERInactive
Code: 059QF0KO0RClass: IACT
PhenytoinActive
Code: 4182431BJHClass: ACTIBQuantity: 50 mg in 1 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 0.4 mL in 1 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACTQuantity: 0.1 mL in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath